Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases - PubMed (original) (raw)
Review
Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases
Sandy S C Hung et al. Pharmacol Ther. 2017 Sep.
Abstract
The revolution of induced pluripotent stem cell (iPSC) technology provides a platform for development of cell therapy, disease modeling and drug discovery. Recent technological advances now allow us to reprogram a patient's somatic cells into induced pluripotent stem cells (iPSCs). Together with methods to differentiate these iPSCs into disease-relevant cell types, we are now able to model disease in vitro using iPSCs. Importantly, this represents a robust in vitro platform using patient-specific cells, providing opportunity for personalized precision medicine. Here we provide a review of advances using iPSC for drug development, and discuss the potential and limitations of iPSCs for drug discovery in neurodegenerative and ocular diseases. Emerging technologies that can facilitate the search for new drugs by assessment using in vitro disease models will also be discussed, including organoid differentiation, organ-on-chip, direct reprogramming and humanized animal models.
Keywords: Disease modeling; Drug discovery; High throughput screening; Induced pluripotent stem cells; Organ-on-chip; Organoid.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
- Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
Corti S, Faravelli I, Cardano M, Conti L. Corti S, et al. Expert Opin Drug Discov. 2015 Jun;10(6):615-29. doi: 10.1517/17460441.2015.1037737. Epub 2015 Apr 20. Expert Opin Drug Discov. 2015. PMID: 25891144 Review. - Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y, Deng W. Liu Y, et al. Brain Res. 2016 May 1;1638(Pt A):30-41. doi: 10.1016/j.brainres.2015.09.023. Epub 2015 Sep 28. Brain Res. 2016. PMID: 26423934 Free PMC article. Review. - A new era of disease modeling and drug discovery using induced pluripotent stem cells.
Suh W. Suh W. Arch Pharm Res. 2017 Jan;40(1):1-12. doi: 10.1007/s12272-016-0871-0. Epub 2016 Dec 5. Arch Pharm Res. 2017. PMID: 27921262 Review. - Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells.
Kawser Hossain M, Abdal Dayem A, Han J, Kumar Saha S, Yang GM, Choi HY, Cho SG. Kawser Hossain M, et al. Int J Mol Sci. 2016 Feb 19;17(2):256. doi: 10.3390/ijms17020256. Int J Mol Sci. 2016. PMID: 26907255 Free PMC article. Review. - Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing.
Yin X, Li Q, Shu Y, Wang H, Thomas B, Maxwell JT, Zhang Y. Yin X, et al. J Biomed Sci. 2024 May 9;31(1):47. doi: 10.1186/s12929-024-01035-4. J Biomed Sci. 2024. PMID: 38724973 Free PMC article. Review.
Cited by
- Current applications of intestinal organoids: a review.
Xiang T, Wang J, Li H. Xiang T, et al. Stem Cell Res Ther. 2024 May 31;15(1):155. doi: 10.1186/s13287-024-03768-3. Stem Cell Res Ther. 2024. PMID: 38816841 Free PMC article. Review. - Challenges and Efficacy of Astrocyte-to-Neuron Reprogramming in Spinal Cord Injury: In Vitro Insights and In Vivo Outcomes.
Niceforo A, Zholudeva LV, Fernandes S, Lane MA, Qiang L. Niceforo A, et al. bioRxiv [Preprint]. 2024 Mar 29:2024.03.25.586619. doi: 10.1101/2024.03.25.586619. bioRxiv. 2024. PMID: 38585866 Free PMC article. Preprint. - Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through.
Jusop AS, Thanaskody K, Tye GJ, Dass SA, Wan Kamarul Zaman WS, Nordin F. Jusop AS, et al. Front Mol Neurosci. 2023 Aug 3;16:1173433. doi: 10.3389/fnmol.2023.1173433. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37602192 Free PMC article. Review. - Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models.
Bigarreau J, Rouach N, Perrier AL, Mouthon F, Charvériat M. Bigarreau J, et al. Int J Mol Sci. 2022 Jan 31;23(3):1684. doi: 10.3390/ijms23031684. Int J Mol Sci. 2022. PMID: 35163606 Free PMC article. Review. - New Technologies to Study Functional Genomics of Age-Related Macular Degeneration.
Nguyen T, Urrutia-Cabrera D, Liou RH, Luu CD, Guymer R, Wong RC. Nguyen T, et al. Front Cell Dev Biol. 2021 Jan 11;8:604220. doi: 10.3389/fcell.2020.604220. eCollection 2020. Front Cell Dev Biol. 2021. PMID: 33505962 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources